Phase 1 Clinical Data with Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Participants (P1-4.003)
To evaluate safety and wake-promoting effects of single and multiple oral doses of ORX750 in a first-in-human clinical study.
Authors
- Emiliangelo Ratti (ORCID: https://orcid.org/0000-0002-7352-4695)
- Saurabh Saha (ORCID: https://orcid.org/0000-0002-0184-7217)
- Jennifer Y. Kong (ORCID: https://orcid.org/0000-0003-4571-3330)
- Deborah Hartman
- Mario Accardi
- Ellie Im
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000209036
- Citations
- 1
- Primary Topic
- Sleep and related disorders
- Type
- article
- Field-Weighted Citation Impact
- 2.12